Brandtree

Who owns Nirvin?

Nirvin is owned by Birzeit Pharmaceutical (Palestine, PEX: BPC).[1]

This ownership is reported in official statements but has not yet been matched to a regulatory filing.

Evidence: Birzeit Pharmaceutical Company — over-the-counter products. Last checked .

Key facts

Current owner
Birzeit Pharmaceutical Company reported
Owner HQ
🇵🇸 Palestine, Birzeit
Origin
🇵🇸 Palestine
Category
Consumer health › Over-the-counter medicine › Cold
Parent ticker
PEX: BPC
Last verified
· 1 sources

About Nirvin

Nirvin is a xylometazoline hydrochloride decongestant sold at 0.5 and 1.0 mg per millilitre. The company says it reduces swelling and congestion within minutes of application and keeps working for up to ten hours, and that the lower strength also serves as a conjunctival decongestant for the eye. Dosing is left to the label rather than fixed, because it differs between patients.

Ownership timeline of Nirvin

  1. Current owner Birzeit Pharmaceutical [1] reported

Where Nirvin sits in Birzeit Pharmaceutical

Controlling ownership as of . Brands grouped under the entity that owns them; large groups are collapsed.

Where Nirvin sits in Birzeit Pharmaceutical Tree of 8 brands under Birzeit Pharmaceutical. Birzeit Pharmaceutical Nirvin Abecedin Dimestil Febramol Fergole Gingival and 2 more

Open the full Birzeit Pharmaceutical ownership tree →

See the full Birzeit Pharmaceutical brand portfolio (8) →

Other brands owned by Birzeit Pharmaceutical

Birzeit Pharmaceutical controls 8 brands on Brandtree, 5 of them in consumer health.

Also in consumer health

All Birzeit Pharmaceutical brands →

Other brands in cold, and who owns them

The 36 brands in cold on Brandtree belong to 21 owners. The largest is Krka, with 5; Birzeit Pharmaceutical has 2.

BrandOwnerOwner based in
Herbion Krka 🇸🇮 Slovenia
Breathe Right Prestige Consumer Healthcare 🇺🇸 United States
Lemsip Reckitt 🇬🇧 United Kingdom
Covonia STADA 🇩🇪 Germany
HealthCareAisle Dr. Reddy's 🇮🇳 India
Tukol Genomma Lab 🇲🇽 Mexico
Benadryl Kenvue 🇺🇸 United States
Allergosan Sopharma 🇧🇬 Bulgaria

Every brand in cold and its owner →

About the owner: Birzeit Pharmaceutical

Birzeit Pharmaceutical is a publicly listed company headquartered in Birzeit, Palestine, founded in 1974. Brandtree records 8 brands under its control, and it is listed as PEX: BPC.

Birzeit Pharmaceutical Company is a Palestinian generic drug maker founded in 1974 in Birzeit, a town about ten kilometres from Ramallah. It started as a private joint stock company with $150,000 of capital and became a public joint stock company in 1979; its shares trade on the Palestine Exchange. It makes around 270 products across 16 production lines at four locations and says it carries roughly 170 brand names. It supplies the Palestinian Ministry of Health alongside pharmacies and doctors, and exports mainly to Eastern Europe. Most of its output is prescription-only; the brands listed here are the ones it sells over the counter.

Birzeit Pharmaceutical: full profile, brands and acquisition history →

🇵🇸 Nirvin and other Palestinian brands

Brandtree records a controlling owner for 9 brands that began in Palestine. 1 of them (11%) are now controlled by a company headquartered in another country; Nirvin is not one of them.

All Palestinian brands and who owns them →

Frequently asked questions

Who is the parent company of Nirvin?

The parent company of Nirvin is Birzeit Pharmaceutical, a publicly listed company headquartered in Palestine.

Is Nirvin Palestinian?

Yes. Nirvin originated in Palestine and its owner, Birzeit Pharmaceutical, is also headquartered in Palestine.

Is Nirvin still owned by Birzeit Pharmaceutical?

Yes. As of 22 September 2026, Nirvin is still owned by Birzeit Pharmaceutical. The ownership record was last checked against primary sources on that date.

Sources (1) & corrections

Last verified . Every ownership fact above is backed by one of these primary documents. Numbers in brackets in the text refer to this list.

  1. [1] Birzeit Pharmaceutical Company — over-the-counter products — Birzeit Pharmaceutical Company, Official document; retrieved 22 September 2026.

Report a correction Opens a pre-filled GitHub issue. See our corrections policy.